🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 67 of 200 · A–Z by INN

  1. eplontersen

    WAINZUA

    EMA: approved

    N07XX21

  2. eplontersen sodium

    WAINUA (AUTOINJECTOR)

    SUBCUTANEOUS FDA: approved

  3. epoetin alfa

    EPOSTIM

    SINGLE-USE FDA: approved · EMA: approved

    B03XA01

  4. epoetin alfa product

    EPREX 20,000 Janssen-Cilag Pty Ltd

    TGA: approved

  5. epoetin alfa-epbx

    RETACRIT

    INJECTION FDA: approved

  6. epoetin beta

    NEORECORMON Hoffmann-La Roche

    EMA: approved · TGA: approved

    B03XA01

  7. epoetin delta

    DYNEPO

    EMA: withdrawn

    B03XA

  8. epoetin lambda

    NOVICRIT Sandoz Pty Ltd

    TGA: approved

  9. epoetin theta

    EPORATIO Teva Pharma GmbH

    EMA: approved

    B03XA01

  10. epoetin zeta

    RETACRIT

    EMA: approved

    B03XA01

  11. epoprostenol

    VELETRI Janssen-Cilag Pty Ltd

    TGA: approved

  12. epoprostenol sodium

    EPOPROSTENOL ACT PARTIAL CHANGE APPROVAL

    INJECTION FDA: approved · PMDA: approved

  13. eprodisate disodium

    KIACTA

    EMA: application withdrawn

  14. eprosartan

    TEVETEN Viatris Pharmaceuticals Co.,

    TGA: approved

  15. eprosartan + hydrochlorothiazide

    TEVETEN PLUS 600/12.5 Viatris Pharmaceuticals Co.,

    TGA: approved

  16. eprosartan mesylate

    TEVETEN

    ORAL FDA: approved

  17. eptacog alfa (activated)

    HEMARYO

    EMA: approved · PMDA: approved

    B02BD08

  18. eptacog beta (activated)

    CEVENFACTA

    EMA: approved

    B02BD08

  19. eptifibatide

    EPTIFIBATIDE ACCORD Teva Pharma GmbH

    INJECTION FDA: approved · EMA: approved

    B01AC16

  20. eptinezumab

    VYEPTI

    EMA: approved · TGA: approved

    N02CD

  21. eptinezumab-jjmr

    VYEPTI

    INJECTION FDA: approved

  22. eptotermin alfa

    OSIGRAFT

    EMA: withdrawn

    M05BC02

  23. eravacycline

    XERAVA

    EMA: approved

    J01AA13

  24. eravacycline dihydrochloride

    XERAVA

    INTRAVENOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources